Optiver Holding
AUPH icon

Optiver Holding’s Aurinia Pharmaceuticals AUPH Stock Holding History

Optiver Holding’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.3K Sell
4,497
-2,318
-34% -$37K ﹤0.01% 1083
2026
Q1 		$101K Buy
6,815
+6,200
+1,008% +$90.6K ﹤0.01% 890
2025
Q4 		$9.81K Sell
615
-76
-11% -$1.08K ﹤0.01% 1149
2025
Q3 		$7.64K Buy
+691
New +$7.55K ﹤0.01% 1458
2024
Q3 		– Sell
-1,785
Closed -$10.2K – 947
2024
Q2 		$10.2K Buy
+1,785
New +$9.4K ﹤0.01% 718

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optiver Holding's AUPH Position: Q2 2026 in Review

Optiver Holding reduced its Aurinia Pharmaceuticals (AUPH) stake by 34% in Q2 2026, selling an estimated $37K and leaving 4,497 shares worth $76.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

Optiver Holding first reported a position in AUPH in Q2 2024 and has held it in 5 quarters since. The position peaked at $101K in Q1 2026. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Optiver Holding held 4,497 shares of Aurinia Pharmaceuticals worth $76.3K as of Q2 2026.
  • Optiver Holding sold 2,318 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $37K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1083 holding.
  • Optiver Holding first reported a position in Aurinia Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • Optiver Holding's Aurinia Pharmaceuticals position peaked at $101K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.